CRH Medical Corp (NASDAQ:CRHM) has been given an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.
Analysts have set a 12 month consensus price objective of $6.35 for the company and are expecting that the company will post $0.05 EPS for the current quarter, according to Zacks. Zacks has also given CRH Medical Corp an industry rank of 112 out of 265 based on the ratings given to its competitors.
Several brokerages have issued reports on CRHM. RBC Capital Markets reaffirmed an “outperform” rating and issued a $6.50 price objective on shares of CRH Medical Corp in a research report on Saturday, October 8th. CIBC reiterated an “outperform” rating on shares of CRH Medical Corp in a research note on Tuesday, September 13th. Zacks Investment Research cut CRH Medical Corp from a “buy” rating to a “hold” rating in a research note on Monday, September 5th. Finally, Canaccord Genuity reiterated a “buy” rating on shares of CRH Medical Corp in a research note on Monday, July 11th.
Several institutional investors have recently added to or reduced their stakes in CRHM. Bank of Montreal Can acquired a new position in CRH Medical Corp during the second quarter valued at approximately $1,258,000. Pacific Ridge Capital Partners LLC purchased a new position in shares of CRH Medical Corp during the second quarter valued at about $1,985,000. TFS Capital LLC purchased a new position in shares of CRH Medical Corp during the second quarter valued at about $138,000. Ativo Capital Management LLC purchased a new position in shares of CRH Medical Corp during the second quarter valued at about $1,076,000. Finally, Sentry Investments Corp. boosted its position in shares of CRH Medical Corp by 1.9% in the second quarter. Sentry Investments Corp. now owns 386,300 shares of the company’s stock valued at $1,943,000 after buying an additional 7,300 shares during the period.
CRH Medical Corp (NASDAQ:CRHM) opened at 4.31 on Friday. The firm has a 50-day moving average of $3.90 and a 200 day moving average of $3.59. CRH Medical Corp has a 52 week low of $2.15 and a 52 week high of $4.72.
CRH Medical Corp Company Profile
CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.